Wiezorek Jeffrey
SVP Clinical Development at Kite Pharma, Inc.
- Sold, on record
- $10M
- Dollars the filings state
- Form 4 sales
- 24
- Latest Sep 25, 2017
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Kite Pharma, Inc.SVP Clinical Development
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Kite Pharma, Inc.Plan not statedNov 10, 2016 2016
Sold 1,500 shares at $50.18 ($75k)
Wiezorek Jeffrey, SVP Clinical Development
Sold 8.7% of holdings ($869k position)15,811 shares left0.2x usual sizeFiling
- 2 Form 4 sale Kite Pharma, Inc.Plan not statedDec 1, 2016 +21 days
Sold 1,500 shares at $50.76 ($76k)
Wiezorek Jeffrey, SVP Clinical Development
Sold 8.7% of holdings ($879k position)15,811 shares left0.2x usual sizeFiling
- 3 Form 4 sale Kite Pharma, Inc.Plan not statedDec 20, 2016 +19 days
Sold 716 shares at $50.86 ($36k)
Wiezorek Jeffrey, SVP Clinical Development
Sold 4.5% of holdings ($804k position)15,095 shares left0.1x usual sizeFiling
- 4 Form 4 sale Kite Pharma, Inc.Plan not statedJan 6, 2017 +17 days
Sold 1,500 shares at $50.00 ($75k)
Wiezorek Jeffrey, SVP Clinical Development
Sold 6.8% of holdings ($1.1M position)20,695 shares left0.2x usual sizeFiling
- 5 Form 4 sale Kite Pharma, Inc.Plan not statedFeb 1, 2017 +26 days
Sold 1,500 shares at $51.21 ($77k)
Wiezorek Jeffrey, SVP Clinical Development
Sold 6.8% of holdings ($1.1M position)20,695 shares left0.2x usual sizeFiling
- 6 Form 4 sale Kite Pharma, Inc.UnusualMar 1, 2017 +28 days
Sold 18,000 shares at $75.01 ($1.4M)
Wiezorek Jeffrey, SVP Clinical Development
Sold 46.1% of holdings ($2.9M position)21,071 shares left2x usual sizeFiling
- 7 Form 4 sale Kite Pharma, Inc.UnusualJul 3, 2017 +124 days
Sold 10,000 shares at $104.32 ($1M)
Wiezorek Jeffrey, SVP Clinical Development
Sold 32.2% of holdings ($3.2M position)21,071 shares left1.7x usual sizeFiling
- 8 Form 4 sale Kite Pharma, Inc.Plan not statedSep 25, 2017 +84 days
Sold 5,283 shares at $179.66 ($949k)
Wiezorek Jeffrey, SVP Clinical Development
Sold 17% of holdings ($5.6M position)25,824 shares left2.3x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (24)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Sep 25, 2017 | Sep 27, 2017 | Kite Pharma, Inc. | SVP Clinical Development | Form 4 sale | 5,283 | $949k | 17.0% | Plan not stated | SEC |
| Jul 3, 2017 | Jul 6, 2017 | Kite Pharma, Inc. | SVP Clinical Development | Form 4 sale | 10,000 | $1M | 32.2% | Unusual | SEC |
| Mar 1, 2017 | Mar 2, 2017 | Kite Pharma, Inc. | SVP Clinical Development | Form 4 sale | 18,000 | $1.4M | 46.1% | Unusual | SEC |
| Feb 1, 2017 | Feb 6, 2017 | Kite Pharma, Inc. | SVP Clinical Development | Form 4 sale | 1,500 | $77k | 6.8% | Plan not stated | SEC |
| Jan 6, 2017 | Jan 10, 2017 | Kite Pharma, Inc. | SVP Clinical Development | Form 4 sale | 1,500 | $75k | 6.8% | Plan not stated | SEC |
| Dec 20, 2016 | Dec 22, 2016 | Kite Pharma, Inc. | SVP Clinical Development | Form 4 sale | 716 | $36k | 4.5% | Plan not stated | SEC |
| Dec 1, 2016 | Dec 5, 2016 | Kite Pharma, Inc. | SVP Clinical Development | Form 4 sale | 1,500 | $76k | 8.7% | Plan not stated | SEC |
| Nov 10, 2016 | Nov 14, 2016 | Kite Pharma, Inc. | SVP Clinical Development | Form 4 sale | 1,500 | $75k | 8.7% | Plan not stated | SEC |
| Oct 3, 2016 | Oct 5, 2016 | Kite Pharma, Inc. | SVP Clinical Development | Form 4 sale | 1,500 | $82k | 8.7% | Plan not stated | SEC |
| Sep 1, 2016 | Sep 2, 2016 | Kite Pharma, Inc. | SVP Clinical Development | Form 4 sale | 1,500 | $87k | 8.7% | Plan not stated | SEC |
| Aug 1, 2016 | Aug 2, 2016 | Kite Pharma, Inc. | SVP Clinical Development | Form 4 sale | 1,500 | $85k | 9.2% | Plan not stated | SEC |
| Jul 1, 2016 | Jul 5, 2016 | Kite Pharma, Inc. | SVP Clinical Development | Form 4 sale | 1,500 | $75k | 9.2% | Plan not stated | SEC |
| Jun 1, 2016 | Jun 2, 2016 | Kite Pharma, Inc. | SVP Clinical Development | Form 4 sale | 3,000 | $152k | 16.8% | Plan not stated | SEC |
| Mar 15, 2016 | Mar 17, 2016 | Kite Pharma, Inc. | SVP Clinical Development | Form 4 sale | 9,000 | $404k | 37.7% | Unusual | SEC |
| Feb 16, 2016 | Feb 18, 2016 | Kite Pharma, Inc. | SVP Clinical Development | Form 4 sale | 9,000 | $397k | 39.6% | Unusual | SEC |
| Jan 15, 2016 | Jan 19, 2016 | Kite Pharma, Inc. | SVP Clinical Development | Form 4 sale | 9,000 | $497k | 39.6% | Unusual | SEC |
| Dec 15, 2015 | Dec 17, 2015 | Kite Pharma, Inc. | SVP Clinical Development | Form 4 sale | 9,000 | $574k | 58.7% | Unusual | SEC |
| Nov 16, 2015 | Nov 18, 2015 | Kite Pharma, Inc. | SVP Clinical Development | Form 4 sale | 9,000 | $703k | 58.7% | Unusual | SEC |
| Oct 15, 2015 | Oct 19, 2015 | Kite Pharma, Inc. | SVP Clinical Development | Form 4 sale | 9,000 | $563k | 58.7% | Unusual | SEC |
| Sep 15, 2015 | Sep 17, 2015 | Kite Pharma, Inc. | VP Clinical Development | Form 4 sale | 9,000 | $579k | 58.7% | Unusual | SEC |
| Aug 17, 2015 | Aug 19, 2015 | Kite Pharma, Inc. | VP Clinical Development | Form 4 sale | 9,000 | $548k | 63.3% | Unusual | SEC |
| Jul 15, 2015 | Jul 20, 2015 | Kite Pharma, Inc. | VP Clinical Development | Form 4 sale | 9,000 | $647k | 63.3% | Unusual | SEC |
| Jun 15, 2015 | Jun 17, 2015 | Kite Pharma, Inc. | VP Clinical Development | Form 4 sale | 9,000 | $513k | 63.3% | Unusual | SEC |
| May 15, 2015 | May 19, 2015 | Kite Pharma, Inc. | VP Clinical Development | Form 4 sale | 9,000 | $451k | 88.1% | Unusual | SEC |